IDeA Networks of Biomedical Research Excellence (INBRE)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-26-026
- Assistance listing (CFDA)
- 93.859
Amount
Amount not published by the funder
Who can apply
Only institutions located in the following states/commonwealth are eligible to apply for the INBRE: Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming.Eligible network partner institutions may be primarily undergraduate institutions (PUIs), defined as four-year colleges and two-year colleges that award associate degrees, bachelor"s degrees, and/or Master"s degrees in biomedical sciences, but have awarded 20 or fewer Ph.D./D.Sc. degrees in biomedical sciences in the previous two academic years; and other higher education and biomedical research institutions.
About this opportunity
The Institutional Development Award program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Networks of Biomedical Research Excellence (INBRE) Notice of Funding Opportunity will support statewide networks in IDeA states made up of one or more research intensive institution and multiple primarily undergraduate institutions. INBREs build biomedical research capacity through supporting faculty research and research mentoring, student participation in research, and enhancement of institutional research infrastructure with an emphasis on developing pathways for undergraduate students in these states to move into biomedical research careers. The INBREs promote collaboration among institutions in IDeA states, create...
Related opportunities
- Centers of Biomedical Research Excellence: Development Phase (COBRE-D)National Institutes of Health
- Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- Funding Opportunity Announcement - NIBIB Technology Development NetworksNational Institutes of HealthUp to $1.0M
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research CentersNational Institutes of Health
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health
- Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)National Institutes of Health